Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain

被引:29
作者
Flick-Smith, HC [1 ]
Waters, EL [1 ]
Walker, NJ [1 ]
Miller, J [1 ]
Stagg, AJ [1 ]
Green, M [1 ]
Williamson, ED [1 ]
机构
[1] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England
关键词
anthrax; vaccine; mouse model;
D O I
10.1016/j.micpath.2004.10.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to evaluate the immunogenicity and protective efficacy of anthrax vaccine candidates a suitable small animal model is required. The inbred A/J strain of mouse has been selected as a potential model, and its immune response to immunisation with recombinant protective antigen (rPA) vaccine characterised, by assessment of rPA specific antibody production, and protection against injected challenge, with the unencapsulated STI strain of Bacillus anthracis. Studies were conducted to determine the time required post immunisation to develop a protective immune response, to define the minimum protective dose of vaccine required and to assess the long-term immune response to immunisation. From the results of these studies it was possible to establish that the A/J mouse is a consistent and robust small animal model fcr rPA vaccine testing. A comparison of the immune response to rPA vaccine immunisation in the Turner Outbred (TO) mouse strain was also conducted. Both inbred and outbred mouse strains displayed a predominantly Th2 biased immune response and showed a comparable antibody response to rPA immunisation. An assessment of protection in the TO mouse against aerosol challenge with the fully virulent strain of B. anthracis, Ames, was also made. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 29 条
[1]   Passive transfer of protection against Bacillus anthracis infection in a murine model [J].
Beedham, RJ ;
Turnbull, PCB ;
Williamson, ED .
VACCINE, 2001, 19 (31) :4409-4416
[2]   IMMUNOELECTROPHORETIC ANALYSIS, TOXICITY, AND KINETICS OF INVITRO PRODUCTION OF THE PROTECTIVE ANTIGEN AND LETHAL FACTOR COMPONENTS OF BACILLUS-ANTHRACIS TOXIN [J].
EZZELL, JW ;
IVINS, BE ;
LEPPLA, SH .
INFECTION AND IMMUNITY, 1984, 45 (03) :761-767
[3]   SERUM PROTEASE CLEAVAGE OF BACILLUS-ANTHRACIS PROTECTIVE ANTIGEN [J].
EZZELL, JW ;
ABSHIRE, TG .
JOURNAL OF GENERAL MICROBIOLOGY, 1992, 138 :543-549
[4]   Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin [J].
Fellows, PF ;
Linscott, MK ;
Ivins, BE ;
Pitt, MLM ;
Rossi, CA ;
Gibbs, PH ;
Friedlander, AM .
VACCINE, 2001, 19 (23-24) :3241-3247
[5]   A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection [J].
Flick-Smith, HC ;
Walker, NJ ;
Gibson, P ;
Bullifent, H ;
Hayward, S ;
Miller, J ;
Titball, RW ;
Williamson, ED .
INFECTION AND IMMUNITY, 2002, 70 (03) :1653-1656
[6]   Anthrax vaccine - Evidence for safety and efficacy against inhalational anthrax [J].
Friedlander, AM ;
Pittman, PR ;
Parker, GW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (22) :2104-2106
[7]  
Glantz S., 1997, PRIMER BIOSTATISTICS
[8]  
González-Fernández A, 1998, IMMUNOLOGY, V93, P149
[9]   DEMONSTRATION OF A CAPSULE PLASMID IN BACILLUS-ANTHRACIS [J].
GREEN, BD ;
BATTISTI, L ;
KOEHLER, TM ;
THORNE, CB ;
IVINS, BE .
INFECTION AND IMMUNITY, 1985, 49 (02) :291-297
[10]   AN APPARATUS FOR THE STUDY OF AIRBORNE INFECTION [J].
HENDERSON, DW .
JOURNAL OF HYGIENE, 1952, 50 (01) :53-68